Limited Significance of Activated Akt-Mammalian Target of Rapamycin Signaling Pathway in Prostate Cancer Progression

Publisher： Karger

E-ISSN： 1423-0399|93|2|146-151

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.93, Iss.2, 2014-02, pp. : 146-151

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

GOLM1 promotes prostate cancer progression through activating PI3K‐AKT‐mTOR signaling

By  

THE PROSTATE, Vol. 78, Iss. 3, 2018-02 ,pp. : 166-177

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia

By  

ANNALS OF NEUROLOGY, Vol. 77, Iss. 4, 2015-04 ,pp. : 720-725

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mammalian Target of Rapamycin as a Rational Therapeutic Target for Breast Cancer Treatment

By  

Oncology, Vol. 84, Iss. 1, 2012-10 ,pp. : 43-56

Karger

Access to resources Recommend Favorite

Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancer

By  

CANCER, Vol. 120, Iss. 4, 2014-02 ,pp. : 603-610

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mammalian target of rapamycin overexpression antagonizes chronic hypoxia-triggered pulmonary arterial hypertension via the autophagic pathway

By                        

International Journal of Molecular Medicine, Vol. 36, Iss. 1, 2015-01 ,pp. : 316-322

Spandidos Publications

Access to resources Recommend Favorite